We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Altered Glycosylation Associated with Dedifferentiation of Hepatocellular Carcinoma

By LabMedica International staff writers
Posted on 16 Mar 2020
Print article
Image: GlycoStation Reader 1200 is an ultra-high speed and highly sensitive optical microarray scanner utilizing the principle of evanescent-field fluorescence excitation to scan an entire microarray slide in only two minutes (Photo courtesy of GlycoTechnica Ltd).
Image: GlycoStation Reader 1200 is an ultra-high speed and highly sensitive optical microarray scanner utilizing the principle of evanescent-field fluorescence excitation to scan an entire microarray slide in only two minutes (Photo courtesy of GlycoTechnica Ltd).
Hepatocellular carcinoma (HCC) is a common cancer with poor prognosis. Liver cancer is the sixth most common type of cancer worldwide, and the fourth most common cause of cancer death. HCC accounts for most primary liver cancers.

Glycosylation is involved in many essential biological processes such as cell differentiation, proliferation, and adhesion; immune response; and receptor activation. However, aberrant glycosylation results in many dysfunctions and diseases. Lectin microarray is a method capable of analyzing glycan profiles comprehensively and sensitively with 45 lectins utilizing lectin specificity to detect specific structures of glycans.

Gastroenterologists at the Oita University Faculty of Medicine (Oita, Japan) analyzed resected 50 HCC specimens using lectin microarray to comprehensively and sensitively analyze glycan profiles. The samples were prepared for laser microdissection by fixing in formalin, embedding in paraffin, then sectioning at a thickness of 5 μm. Lectin microarray was performed and performed immunohistochemical staining of mannosyl(α-1,3-)-glycoprotein β-1,2-N-acetylglucosaminyltransferase (MGAT1), which is an essential glycosyltransferase that converts high-mannose glycans to complex- or hybrid-type N-glycans. Fluorescent images were obtained with the GlycoStation Reader 1200 (GlycoTechnica Ltd, Yokohama, Japan) using the evanescent-wave excitation method.

The scientists reported that four lectins from Narcissus pseudonarcissus agglutinin (NPA), Concanavalin A, Galanthus nivalis agglutinin, and Calystegia sepium agglutinin were significantly elevated in moderately-differentiated components of HCC compared with well-differentiated components, and all lectins showed binding specificity to high-mannose glycans. All the lectins showed specificity to high-mannose glycan structures and none were significantly decreased by dedifferentiation. Immunohistochemical staining revealed significantly increased NPA expression and decreased MGAT1 expression in moderately-differentiated components. Low MGAT1 expression in moderately-differentiated components of tumors was associated with intrahepatic metastasis and had tendency for poor prognosis.

The authors concluded that dedifferentiation of well-differentiated HCC is associated with increased high-mannose glycans. Furthermore, MGAT1 may play a role in HCC dedifferentiation. The study was published on March 6, 2020 in the journal BMC Cancer.

Related Links:
Oita University Faculty of Medicine
GlycoTechnica Ltd


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.